Differentially expressed nonmitochondrial proteins (DEP) with decreased expression comparing horses susceptible to recurrent exertional rhabdomyolysis with control. by Kennedy Aldrich (10125669)

Differentially expressed mitochondrial proteins (DEP) with decreased expression comparing horses susceptible to recurrent exertional rhabdomyolysis with control. by Kennedy Aldrich (10125669)

Tryptophan and metabolite alterations in response to a control diet or a diet containing MCOA. by Natalie E. Diether (16705804)

Growth kinetics of Measles viruses in Vero and THP-1 cell lines. by Pierre Khalfi (7868252)

Response rate of patients with <i>CYP3A4</i> and <i>CYP3A5</i> polymorphisms after tacrolimus initiation. by Maizumi Furuse (10688237)

“…Clinical response was defined as a partial Mayo score reduction of ≥2 points accompanied by a decrease of at least 30% from baseline and a decrease in the rectal bleeding subscore of ≥1 or an absolute rectal bleeding subscore of 0 or 1. …”

Oral UOX decreased SUA (A), BUN (B) and Cr (C) (mean ± SD, n = 10). by Yu Yun (4710340)

CX treatment leads to decreased perfusion and increased leakage after VEGF-A induced angiogenesis. by Mattias Kalén (224600)

Image_5_Identification of Sorafenib as a Treatment for Type 1 Diabetes.tif by Qin Zeng (166641)

24 h fasting decreases mARC protein levels and <i>N</i>-reductive activity in mice. by Heyka H. Jakobs (619421)

Effects of adenosine receptor-specific antagonists on responses to hypoxia at E9.5 and E12.5. by Daniela L. Buscariollo (140729)

“…<p>A and B: Specimens were treated with DPCPX, an A1AR-specific antagonist at 10 nM (A: E9.5, n = 15; B: E12.5, n = 23), SCH-58261, an A2aAR-specific antagonist at 100 nM (A: E9.5, n = 15; B: E12.5, n = 19), or vehicle (A: E9.5, n = 27; B: E12.5, n = 42) at 15 min (arrows), and exposed to hypoxia (gray boxes). …”

Fig 5 - by Qingxi Shen (3547970)

GPT-4 results in decreased error rate for all tasks with increasing complexity when compared to GPT-3.5-turbo. by Jacqueline A. Jansen (14894276)

PowerPoint Slides for: Urinary Periostin Excretion Predicts Renal Outcome in IgA Nephropathy by Hwang J.H. (3300987)

Schematic diagram of the track and latch comparator (a) conventional track and latch comparator (b) small signal model of the comparator. by Labonnah Farzana Rahman (641767)

Replacement of <i>RPL22B</i> promoter by the GAL promoter results in a decrease in alternative 5′-splice site usage. by Tadashi Kawashima (550396)

TR4 and TR9 decrease hepatoma cell viability at a lower TC50 than Sorafenib, SAHA or 5-Fluorouracil. by Nicole Lange (335740)

Binding sensogram (a) showing decrease in frequency of crystal immobilised with 1.5 M short aptamer exposed to different concentrations of heparanase. by Suzanne C. Simmons (319222)

“…<p>Higher concentrations of heparanase exhibited a greater decrease in frequency. Binding and regeneration sensogram (b) for addition of 800 nM heparanase to a quartz crystal immobilised with 1.5 M short aptamer. …”

Image_5_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIF by Rohit Moudgil (540119)

Predicting alternans in the V_m-driven model during a progressive decrease of I_Ks conductance. by Mathieu Lemay (330649)

Image_5_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIF by Rohit Moudgil (540119)